AzTrials
AzTrials

Pregnancy GingivitisNCT04140643

Ozone Therapy for the Home Oral Hygiene of the Pregnant Woman.

A study testing Ozonated water delivering device effects on the oral health of pregnant women and Oral hygiene instructions in people with Pregnancy Gingivitis and Ozone, run by IRCCS San Raffaele at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the present study is analyzing the effect of an domestic ozonated water delivering device on the oral health status of pregnant women. Two groups of 30 women will be enrolled following a simple randomization scheme: the group A will be equipped with a domestic ozonated water delivering device and a control… Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy Gingivitis, Ozone
What is being tested?
Ozonated water delivering device effects on the oral health of pregnant women and Oral hygiene instructions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteItaly
Study dates
1 Mar 2019to 30 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • legal age
  • pregnancy period between the 14 and 30 week
  • diagnosis positive for pregnancy gingivitis
  • presence of at least 20 teeth

Who cannot join

  • absumption of alcohol during pregnancy
  • systemic diseases
  • chronic drug assumption
  • allergies
  • ongoing orthodontic therapies
  • positive periodontal screening recording (PSR) at T1

Trial locations and contacts

1 site in 1 country.

Simona Tecco, DDS, MS, PhD contact

+39 3297838023

tecco.simona@hsr.it

Italy1 site, 1 recruiting
  • Dental Clinic, IRCCS San Raffaele Hospital

    Milan, MI, 20132

    Simona Tecco, DDS, MS, PhD, +39 3297838023, tecco.simona@hsr.it

    Simona Tecco, DDS, MS, PhD

    Recruiting

Other trials in Italy

About this study

Official title: Ozone Therapy as an Aid for Home Oral Hygiene. The Use of Aquolab in the Pregnant Woman.

The aim of the present study is analyzing the effect of an domestic ozonated water delivering device on the oral health status of pregnant women.

Two groups of 30 women will be enrolled following a simple randomization scheme: the group A will be equipped with a domestic ozonated water delivering device and a control group B that will not be equipped with the device. The sample size was calculated with a power analysis performed starting from descriptive data differences obtained from a pilot study in order to achieve a power higher than 80 percent with an alpha error of 0.05 resulting in a minimum of 27 participants for each group.

Read more

The protocol was in accordance with the Declaration of Helsinki and was approved by the Ethical Committee of the IRCCS San Raffaele Hospital, all the participants will be informed about the aim of the study and will sign an informed consent form.

At the first examination (T0) the clinical oral hygiene parameters will be recorded on the enrolled participants of both the groups and they will be subjected to a professional oral hygiene procedure with appropriate home oral hygiene instructions. The same clinical oral hygiene parameters will be recorded also after 15 days (T1) and after 75 days (T2) from the first examination.

All the clinical procedures and data recording will be conducted by the operator X blind to the participants group while the operator Y will give the device and instruct the participants to its proper use.

After a descriptive analysis of the data, an analysis of the data distribution will be performed with the Kolmogorov-Smirnov test. According with the result of the data distribution analysis the differences between-groups and within-groups will be evaluated with the proper parametric or non-parametric test.

Read the detailed description

The aim of the present study is analyzing the effect of an domestic ozonated water delivering device on the oral health status of pregnant women.

In the present study a total of 60 pregnant women will be recruited at the dental clinic of the IRCCS San Raffaele Hospital. These participants must adhere to the following inclusion criteria: legal age, pregnancy period between the 14 and 30 week, diagnosis positive for pregnancy gingivitis, presence of at least 20 teeth. The following exclusion criteria will be applied: absumption of alcohol during pregnancy, systemic diseases, chronic drug assumption, allergies, ongoing orthodontic therapies, positive periodontal screening recording (PSR).

The participants will be assigned to two groups following a simple randomization scheme: the group A will be equipped with a domestic ozonated water delivering device (Aquolab®, EB2C, Milan, Italy) and a control group B that will not be equipped with the device. The sample size was calculated with a power analysis performed starting from descriptive data differences obtained from a pilot study in order to achieve a power higher than 80 percent with an alpha error of 0.05 resulting in a minimum of 27 participants for each group. A total of 30 subjects will be assigned to each group in order to prevent possible drop-outs.

The protocol was in accordance with the Declaration of Helsinki and was approved by the Ethical Committee of the IRCCS San Raffaele Hospital, all the participants will be informed about the aim of the study and will sign an informed consent form.

At the first examination (T0) the clinical oral hygiene parameters will be recorded on the enrolled participants of both the groups and they will be subjected to a professional oral hygiene procedure with appropriate home oral hygiene instructions. The same clinical oral hygiene parameters will be recorded also after 15 days (T1) and after 75 days (T2) from the first examination.

All the clinical procedures and data recording will be conducted by the operator X blind to the participants group while the operator Y will give the device and instruct the participants to its proper use.

After a descriptive analysis of the data, an analysis of the data distribution will be performed with the Kolmogorov-Smirnov test. According with the result of the data distribution analysis the differences between-groups and within-groups will be evaluated with the proper parametric or non-parametric test.

Being tested
Ozonated water delivering device effects on the oral health of pregnant women, Oral hygiene instructions
Keywords
Pregnancy, Oral Health, Ozone therapy, Gingivitis
Medical subject headings
Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ozonated water delivering device effects on the oral health of pregnant womenDevice

    Oral Hygiene instructions and use of an ozonated water delivering device in pregnant women for a period of 75 days.

  • Oral hygiene instructionsBehavioural

    Oral Hygiene instructions

Study groups in NCT04140643
Study groupRoleWhat they receive
Ozone therapyExperimentalOral hygiene instructions given by dental hygienist and home daily use of ozonated water delivering system.
Receives: Device: Ozonated water delivering device effects on the oral health of pregnant women
Only oral hygiene instructionsActive comparatorOral hygiene instructions given by dental hygienist.
Receives: Behavioral: Oral hygiene instructions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Periodontal Screening Recording (PSR)

    Code 0 - Colored area of probe remains completely visible in the deepest crevice in the sextant. No calculus or defective margins are detected. Gingival tissues are healthy with no bleeding after gentle probing.

    • Code 1 - Colored area of probe remains completely visible in the deepest probing depth in the sextant. No calculus or margins are detected. There is bleeding after gentle probing.
    • Code 2 - Colored area of probe remains completely visible in the deepest probing depth in the sextant. Supra- or subgingival calculus and/or defective margins are detected.

    Code 3 - Colored area of probe remains partly visible in the deepest probing depth in the sextant.

    • Code 4 - Colored area of probe completely disappears, indicating probing depth of greater than 5.5 mm.

    Measured: 60 Days

Secondary outcomes (3)
  1. Bleeding of Probing (BOP)

    Expressed as Full Mouth Bleeding Score (FMPS), percentage of bleeding sites on the total number of available sites.

    Measured: 60 Days

  2. Plaque Index (PI)

    Expressed as Full Mouth Plaque Score (FMPS), percentage of plaque containing dental surfaces on the total number of available surfaces.

    Measured: 60 Days

  3. Probing Depth (PD)

    Measured: 60 Days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2019
  2. Study start1 Mar 2019
  3. Primary completion30 Nov 2020 (estimated)
  4. Study completion30 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04140643
Sponsor's protocol ID
EB2C
Status last verified
Jul 2020
First submitted
3 May 2019
Last updated
29 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Geisinger ML, Geurs NC, Bain JL, Kaur M, Vassilopoulos PJ, Cliver SP, Hauth JC, Reddy MS. Oral health education and therapy reduces gingivitis during pregnancy. J Clin Periodontol. 2014 Feb;41(2):141-8. doi: 10.1111/jcpe.12188. Epub 2013 Nov 19.

    PubMed 24164645
  • Jiang H, Xiong X, Buekens P, Su Y, Qian X. Use of mouth rinse during pregnancy to improve birth and neonatal outcomes: a randomized controlled trial. BMC Pregnancy Childbirth. 2015 Nov 25;15:311. doi: 10.1186/s12884-015-0761-3.

    PubMed 26608342
  • Villa A, Abati S, Pileri P, Calabrese S, Capobianco G, Strohmenger L, Ottolenghi L, Cetin I, Campus GG. Oral health and oral diseases in pregnancy: a multicentre survey of Italian postpartum women. Aust Dent J. 2013 Jun;58(2):224-9. doi: 10.1111/adj.12058. Epub 2013 May 5.

    PubMed 23713644
  • Almerich-Silla JM, Alminana-Pastor PJ, Boronat-Catala M, Bellot-Arcis C, Montiel-Company JM. Socioeconomic factors and severity of periodontal disease in adults (35-44 years). A cross sectional study. J Clin Exp Dent. 2017 Aug 1;9(8):e988-e994. doi: 10.4317/jced.54033. eCollection 2017 Aug.

    PubMed 28936289
  • Tecco S, Nota A, D'Amicantonio T, Pittari L, Monti M, Polizzi E. Effects of an Ozonated Water Irrigator on the Plaque Index and Bleeding Index of Pregnant Women. J Clin Med. 2022 Jul 15;11(14):4107. doi: 10.3390/jcm11144107.

    PubMed 35887871

Questions about this trial

What is this clinical trial studying?

A study testing Ozonated water delivering device effects on the oral health of pregnant women and Oral hygiene instructions in people with Pregnancy Gingivitis and Ozone, run by IRCCS San Raffaele at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Simona Tecco, DDS, MS, PhD (+39 3297838023, tecco.simona@hsr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Periodontal Screening Recording (PSR) (time frame: 60 Days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04140643, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in